What Is TB-500?

TB-500 is a synthetic peptide derived from the active region of Thymosin Beta-4 (TB4), a naturally occurring 43-amino-acid protein involved in cell migration, tissue repair, and anti-inflammatory signaling. It works primarily through its interaction with actin, the protein responsible for cell structure and movement.

Because TB-500 supports healing at the cellular level, dosing must balance effective tissue concentrations with safety. Unlike pharmaceutical drugs with established dosing guidelines from Phase III trials, TB-500 dosing is informed by a smaller body of published research, animal pharmacokinetics, and clinical observation by practitioners experienced in peptide therapy.

Why Dosing Matters for Peptide Therapy

Peptides are not one-size-fits-all compounds. Their effects depend on factors including body weight, the condition being addressed, individual metabolism, and the quality of the compound itself. Underdosing may produce no measurable benefit, while excessive dosing increases the likelihood of side effects without proportional gains.

TB-500 is generally considered to have a wide therapeutic window, meaning the difference between an effective dose and a harmful dose is relatively large. However, this does not eliminate the need for clinical judgment. A physician can account for variables that generic protocols cannot.

Standard TB-500 Dosing Protocols

The most commonly referenced dosing protocols for TB-500 follow a two-phase structure. These are based on clinical observation and practitioner experience rather than large-scale human clinical trials. Individual protocols may vary.

Loading Phase

The loading phase is designed to build up tissue-level concentrations of TB-500 and initiate the repair cascade.

• Dose: 2.0 mg to 2.5 mg per injection
• Frequency: Twice per week
• Duration: 4 to 6 weeks
• Total weekly dose: 4 mg to 5 mg

Some practitioners prescribe a higher loading dose of up to 5 mg twice weekly for the first two weeks in cases of acute injury, though this approach is less common and should only be undertaken with direct physician oversight.

Maintenance Phase

Once the loading phase is complete, dosing is typically reduced to sustain benefits while minimizing cumulative exposure.

• Dose: 2.0 mg to 2.5 mg per injection
• Frequency: Once per week or once every two weeks
• Duration: 4 to 8 weeks, or as directed by your physician
• Total weekly dose: 2 mg to 2.5 mg (or less)

Cycle Length

A full TB-500 cycle typically runs 8 to 12 weeks (loading plus maintenance). Some practitioners recommend a washout period of 4 to 6 weeks between cycles, though the optimal rest period has not been established in human trials. Your physician will advise on whether additional cycles are appropriate based on your response.

Factors That Influence Dosing

Body Weight

Larger individuals may require doses at the higher end of the range to achieve comparable tissue concentrations. Some practitioners calculate dosing on a per-kilogram basis, though standardized weight-based protocols have not been validated in clinical trials.

Severity of Condition

Acute injuries or significant tissue damage may warrant a more aggressive loading phase. Chronic, low-grade inflammation or maintenance-oriented protocols may call for lower doses.

Concurrent Peptides

TB-500 is sometimes used alongside BPC-157, another tissue-repair peptide with complementary mechanisms. When peptides are stacked, dosing adjustments may be necessary. Only a physician familiar with peptide pharmacology should design combination protocols.

Individual Response

Some individuals respond well to lower doses, while others require doses at the upper end of the range. Starting conservatively and titrating upward based on response is a common clinical approach.

Timing and Administration

When to Inject

TB-500 can be administered at any time of day. Some users prefer evening injections due to the mild fatigue that can occur after administration. There is no published evidence that timing relative to meals or exercise significantly affects efficacy.

Route of Administration

TB-500 is most commonly administered via subcutaneous injection. Intramuscular injection is also used by some practitioners, particularly when targeting a specific area of injury. The subcutaneous route is generally preferred for systemic distribution.

Injection Spacing

When dosing twice weekly, spacing injections 3 to 4 days apart (for example, Monday and Thursday) helps maintain more consistent peptide levels. There is no strong evidence that precise timing matters beyond maintaining reasonable consistency.

Reconstitution and Storage

TB-500 is typically supplied as a lyophilized (freeze-dried) powder that must be reconstituted with bacteriostatic water before injection.

• Reconstitution: Add bacteriostatic water slowly along the side of the vial. Do not shake. Gently swirl until dissolved.
• Common reconstitution volume: 1 mL to 2 mL of bacteriostatic water per vial, depending on the concentration needed.
• Storage after reconstitution: Refrigerate at 2 to 8 degrees Celsius (36 to 46 degrees Fahrenheit). Use within 3 to 4 weeks.
• Unreconstituted storage: Lyophilized powder can be stored frozen or refrigerated for longer periods. Check manufacturer guidelines for specific shelf life.

Always follow the specific reconstitution and storage instructions provided by your compounding pharmacy.

Common Dosing Mistakes to Avoid

• Skipping the loading phase: Maintenance-level doses from the start may not build sufficient tissue concentrations to produce noticeable benefits.
• Exceeding recommended doses: More is not necessarily better. Higher doses increase the risk of side effects without established evidence of proportionally greater benefit.
• Inconsistent dosing: Sporadic injections make it difficult to maintain therapeutic levels and may reduce efficacy.
• Using degraded product: Peptides that have been improperly stored, reconstituted with non-bacteriostatic water, or kept too long after reconstitution may be ineffective or contaminated.
• Self-prescribing without medical oversight: Individual health factors, medications, and contraindications must be assessed by a physician.

Safety Considerations

TB-500 has shown a generally favorable safety profile in published research, with most reported side effects being mild and transient. Common side effects at standard doses include temporary fatigue, mild headache, and injection-site reactions.

Important safety notes:

• TB-500 is not FDA-approved for any indication.
• Individuals with active cancer or a history of cancer should avoid TB-500 due to its pro-angiogenic properties.
• Pregnant or breastfeeding individuals should not use TB-500.
• All dosing should be supervised by a licensed medical provider.

How Form Blends Can Help

Dosing peptides correctly requires more than a chart from the internet. It requires clinical judgment, quality compounds, and ongoing monitoring. Form Blends offers all three through its physician-supervised telehealth platform.

• Physician-designed protocols: Your dose, frequency, and cycle length are determined by a licensed provider based on your medical history and goals.
• Pharmacy-grade peptides: Compounds are sourced from licensed compounding pharmacies with verified potency and purity.
• Clear instructions: You receive detailed guidance on reconstitution, injection technique, and storage.
• Dose adjustments: Your provider monitors your progress and can modify your protocol if needed.

Getting the dose right is the foundation of effective peptide therapy. Form Blends makes sure you start with that foundation in place.